Back to company

ABBLO PHARMA ApS: Financial statements 2018

CVR: 34080534

ABBLO PHARMA ApS (CVR 34080534) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 145,533 and a net result of DKK 12,115 compared with DKK -84,087 the year before. That is an increase of 21.6% compared with the year before. Equity amounted to DKK -1,228,738. The company had 1 employee in the financial year.

Gross Profit
145,533 kr.
Profit/Loss
12,115 kr.
Equity
-1,228,738 kr.
Total Assets
576,297 kr.
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2018-146 t.12 t.-1.2 mio.1
2017-120 t.-84 t.-1.2 mio.1
2016--217 t.-380 t.-1.2 mio.1
2014--126 t.2 mio.-215 t.-
2013--12 t.-2.7 mio.-2.2 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on ABBLO PHARMA ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2018

ABBLO PHARMA ApS: The 2017 annual report is outMar 23, 2018

ABBLO PHARMA ApS has published its annual report for 2017. Gross profit came to DKK 119,645, and the net result was DKK -84,087.

About ABBLO PHARMA ApS

ABBLO PHARMA ApS is a Danish company of the type Anpartsselskab based in Charlottenlund, founded in 2011. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Nic Borch-Christensen and Mie Hjerrild Petersen. The company is owned by ABBLO S.à.r.l. The company has 0 employees. In 2025, the company reported a gross profit of DKK 471,866 and a net result of DKK -152,259 compared with DKK 135,215 the year before. Equity amounted to DKK -238,088.